EUVIMEDEUVIMED entdecken
Crossref

In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer

Michelino De Laurentiis iD, Roberto Buonaiuto, Giuseppe Buono, Roberta Caputo, Carmine De Angelis

Journal of Clinical Oncology · 10.12.2025 · 43 (35) · 3691-3697

DOI: 10.1200/jco-25-01440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.12.2025. Verfasst von Michelino De Laurentiis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Nazionale Tumori Napoli IRCCS "Fondazione Pascale," Naples, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Istituto Nazionale Tumori Napoli IRCCS "Fondazione Pascale," Naples, Italy.
  • Clinical and Translational Oncology, Scuola Superiore Meridionale University, Naples, Italy.

ORCID-Profile: Michelino De Laurentiis

Zitieren

APA

De Laurentiis, M., Buonaiuto, R., Buono, G., Caputo, R., & De Angelis, C. (2025). In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer. Journal of Clinical Oncology, 43(35), 3691-3697. https://doi.org/10.1200/jco-25-01440

Vancouver

De Laurentiis M, Buonaiuto R, Buono G, Caputo R, De Angelis C. In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer. Journal of Clinical Oncology. 2025;43(35):3691-3697. doi:10.1200/jco-25-01440

BibTeX
@article{DeLaurentiis2025,
  author = {De Laurentiis, Michelino and Buonaiuto, Roberto and Buono, Giuseppe and Caputo, Roberta and De Angelis, Carmine},
  title = {In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  volume = {43},
  number = {35},
  pages = {3691--3697},
  doi = {10.1200/jco-25-01440}
}
Kostenlos starten →